PAKIANATHAN DEEPIKA 4

Accession 0000950170-24-100281

CIK 0001719714other

View on SEC.gov Company Profile

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 6:13 PM ET

Size

27.5 KB

Accession

0000950170-24-100281

Insider Transaction Report

Form 4

Period: 2024-08-22

Mereo BioPharma Group plcMREO

PAKIANATHAN DEEPIKA

Director

Transactions

Exercise/Conversion
Share Options (right to buy)
2024-08-22−55,000→ 0 total
Exercise: $0.94Exp: 2033-02-01→ American Depository Shares (55,000 underlying)
Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-08-22$1.84/sh+6,492$11,945→ 8,317 total
Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-08-22$3.87/sh+2,071$8,015→ 105,244 total
Exercise/Conversion
Share Options (right to buy)
2024-08-22−5,500→ 0 total
Exercise: $3.00Exp: 2029-07-23→ American Depository Shares (5,500 underlying)
Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-08-22$1.31/sh+38,953$51,028→ 59,688 total
Sale
American Depositary Shares representing Ordinary Shares
2024-08-22$4.43/sh−105,244$466,210→ 0 total
Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-08-22$3.00/sh+1,825$5,475→ 1,825 total
Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-08-22$2.72/sh+12,418$33,777→ 20,735 total
Exercise/Conversion
Share Options (right to buy)
2024-08-22−11,000→ 0 total
Exercise: $1.84Exp: 2030-02-20→ American Depository Shares (11,000 underlying)
Exercise/Conversion
Share Options (right to buy)
2024-08-22−31,500→ 0 total
Exercise: $2.72Exp: 2031-02-01→ American Depository Shares (31,500 underlying)
Exercise/Conversion
Share Options (right to buy)
2024-08-22−55,000→ 0 total
Exercise: $1.31Exp: 2032-02-01→ American Depository Shares (55,000 underlying)
Exercise/Conversion
Share Options (right to buy)
2024-08-22−15,000→ 30,000 total
Exercise: $3.87Exp: 2034-02-08→ American Depository Shares (15,000 underlying)
Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-08-22$0.94/sh+43,485$40,876→ 103,173 total

Footnotes (9)

[F1]Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer.
[F2]Sale is due to fund administration reasons.
[F3]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.360 to $4.495, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc ("Mereo"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnote (3) to this Form
[F4]Vested in substantially equal monthly installments over a one year period from the July 23, 2019 grant date.
[F5]Vested in substantially equal monthly installments over a one year period from the February 20, 2020 grant date.
[F6]Vested in substantially equal monthly installments over a one year period from the February 1, 2021 grant date.
[F7]Vested in substantially equal monthly installments over a one year period from the February 1, 2022 grant date.
[F8]Vested in substantially equal monthly installments over a one year period from the February 1, 2023 grant date.
[F9]Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date. As of June 8, 2024, 15,000 Share Options have vested.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Mereo BioPharma Group plc

CIK 0001719714

→

Entity typeother

Related Parties

filerCIK 0001270734

Filing Metadata

Form type: 4
Filed: Aug 22, 8:00 PM ET
Accepted: Aug 23, 6:13 PM ET
Size: 27.5 KB

View on SEC.gov